Adaptive Response of Group B Streptococcus to High Glucose Conditions: New Insights on the CovRS Regulation Network

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Di Palo, Benedetta ^a   Rippa, Valentina ^a   Santi, Isabella ^b   Brettoni, Cecilia ^a   Muzzi, Alessandro ^a   Metruccio, Matteo Maria Emiliano ^a   Grifantini, Renata ^c   Telford, John L ^a   Paccani, Silvia Rossi ^a   Soriani, Marco ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b EPFL   (Switzerland)

^c Externautics SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSULE SYNTHESIS REGULATOR; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADAPTATION; ARC 2 GENE; ARG F 2 GENE; ARTICLE; BACTERIAL GENE; BIBA GENE; BINDING AFFINITY; CAPSULE SYNTHESIS REGULATOR GENE; CARBON SOURCE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYDC GENE; DOWN REGULATION; EDA 2 GENE; ENERGY METABOLISM; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE REGULATORY NETWORK; GLUCOSE METABOLISM; HOST PATHOGEN INTERACTION; METABOLIC GENE; MSMK GENE; NONHUMAN; PROMOTER REGION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REGULATOR GENE; STREPTOCOCCUS AGALACTIAE; STRESS RESPONSE GENE; TRANSCRIPTION REGULATION; TRANSPORT GENE; UPREGULATION;

ADAPTATION, BIOLOGICAL; ADHESINS, BACTERIAL; ESCHERICHIA COLI; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENES, REGULATOR; GLUCOSE; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECOMBINANT PROTEINS; STREPTOCOCCUS AGALACTIAE; TRANSCRIPTION, GENETIC;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS SP. 'GROUP B';

EID: 84876039381     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061294     Document Type: Article

References (52)

1. Johri AK, Paoletti LC, Glaser P, Dua M, Sharma PK, et al. (2006) Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 4: 932-942.
2. Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, et al. (2009) Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 49: 85-92.
3. Farley MM, Harvey RC, Stull T, Smith JD, Schuchat A, et al. (1993) A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med 328: 1807-1811.
4. Jackson LA, Hilsdon R, Farley MM, Harrison LH, Reingold AL, et al. (1995) Risk factors for group B streptococcal disease in adults. Ann Intern Med 123: 415-420.
5. Schwartz B, Schuchat A, Oxtoby MJ, Cochi SL, Hightower A, et al. (1991) Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA 266: 1112-1114.
6. Domingo P, Barquet N, Alvarez M, Coll P, Nava J, et al. (1997) Group B streptococcal meningitis in adults: report of twelve cases and review. Clin Infect Dis 25: 1180-1187.
7. Yanai H, Hamasaki H, Tsuda N, Adachi H, Yoshikawa R, Moriyama S, et al. (2012) Group B streptococcus infection and diabetes: A review. Journal of Microbiology and Antimicrobials 4: 1-5.
8. Edwards MS, Baker CJ, (2005) Group B streptococcal infections in elderly adults. Clin Infect Dis 41: 839-847.
9. Mazade MA, Edwards MS, (2001) Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes. Mol Genet Metab 73: 259-267.
10. Almengor AC, Kinkel TL, Day SJ, McIver KS, (2007) The catabolite control protein CcpA binds to Pmga and influences expression of the virulence regulator Mga in the Group A streptococcus. J Bacteriol 189: 8405-8416.
11. Shelburne SA, Davenport MT, Keith DB, Musser JM, (2008) The role of complex carbohydrate catabolism in the pathogenesis of invasive streptococci. Trends Microbiol 16: 318-325.
12. Jiang SM, Cieslewicz MJ, Kasper DL, Wessels MR, (2005) Regulation of virulence by a two-component system in group B streptococcus. J Bacteriol 187: 1105-1113.
13. Lamy MC, Zouine M, Fert J, Vergassola M, Couve E, et al. (2004) CovS/CovR of group B streptococcus: a two-component global regulatory system involved in virulence. Mol Microbiol 54: 1250-1268.
14. Mereghetti L, Sitkiewicz I, Green NM, Musser JM, (2009) Identification of an unusual pattern of global gene expression in group B Streptococcus grown in human blood. PLoS One 4: e7145.
15. Sitkiewicz I, Green NM, Guo N, Bongiovanni AM, Witkin SS, et al. (2009) Transcriptome adaptation of group B Streptococcus to growth in human amniotic fluid. PLoS One 4: e6114.
16. Santi I, Grifantini R, Jiang SM, Brettoni C, Grandi G, et al. (2009) CsrRS regulates group B Streptococcus virulence gene expression in response to environmental pH: a new perspective on vaccine development. J Bacteriol 191: 5387-5397.
17. Tettelin H, Masignani V, Cieslewicz MJ, Eisen JA, Peterson S, et al. (2002) Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A 99: 12391-12396.
18. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
19. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
20. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
21. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
22. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
23. Jiang SM, Ishmael N, Dunning Hotopp J, Puliti M, Tissi L, et al. (2008) Variation in the group B Streptococcus CsrRS regulon and effects on pathogenicity. J Bacteriol 190: 1956-1965.
24. Gruening P, Fulde M, Valentin-Weigand P, Goethe R, (2006) Structure, regulation, and putative function of the arginine deiminase system of Streptococcus suis. J Bacteriol 188: 361-369.
25. Janulczyk R, Ricci S, Bjorck L, (2003) MtsABC is important for manganese and iron transport, oxidative stress resistance, and virulence of Streptococcus pyogenes. Infect Immun 71: 2656-2664.
26. Papp-Wallace KM, Maguire ME, (2006) Manganese transport and the role of manganese in virulence. Annu Rev Microbiol 60: 187-209.
27. Warren MA, Kucharski LM, Veenstra A, Shi L, Grulich PF, et al. (2004) The CorA Mg2+ transporter is a homotetramer. J Bacteriol 186: 4605-4612.
28. Samen U, Gottschalk B, Eikmanns BJ, Reinscheid DJ, (2004) Relevance of peptide uptake systems to the physiology and virulence of Streptococcus agalactiae. J Bacteriol 186: 1398-1408.
29. Shah P, Nanduri B, Swiatlo E, Ma Y, Pendarvis K, (2011) Polyamine biosynthesis and transport mechanisms are crucial for fitness and pathogenesis of Streptococcus pneumoniae. Microbiology 157: 504-515.
30. Hoffmann T, Schutz A, Brosius M, Volker A, Volker U, et al. (2002) High-salinity-induced iron limitation in Bacillus subtilis. J Bacteriol 184: 718-727.
31. Hoffmann T, Bremer E, (2011) Protection of Bacillus subtilis against cold stress via compatible-solute acquisition. J Bacteriol 193: 1552-1562.
32. Obis D, Guillot A, Gripon JC, Renault P, Bolotin A, et al. (1999) Genetic and biochemical characterization of a high-affinity betaine uptake system (BusA) in Lactococcus lactis reveals a new functional organization within bacterial ABC transporters. J Bacteriol 181: 6238-6246.
33. Pritzlaff CA, Chang JC, Kuo SP, Tamura GS, Rubens CE, et al. (2001) Genetic basis for the beta-haemolytic/cytolytic activity of group B Streptococcus. Mol Microbiol 39: 236-247.
34. Lang S, Palmer M, (2003) Characterization of Streptococcus agalactiae CAMP factor as a pore-forming toxin. J Biol Chem 278: 38167-38173.
35. Spellerberg B, Rozdzinski E, Martin S, Weber-Heynemann J, Schnitzler N, et al. (1999) Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin. Infect Immun 67: 871-878.
36. Poyart C, Pellegrini E, Gaillot O, Boumaila C, Baptista M, et al. (2001) Contribution of Mn-cofactored superoxide dismutase (SodA) to the virulence of Streptococcus agalactiae. Infect Immun 69: 5098-5106.
37. Brady LJ, Maddocks SE, Larson MR, Forsgren N, Persson K, et al. (2010) The changing faces of Streptococcus antigen I/II polypeptide family adhesins. Mol Microbiol 77: 276-286.
38. Yamamoto Y, Poyart C, Trieu-Cuot P, Lamberet G, Gruss A, et al. (2005) Respiration metabolism of Group B Streptococcus is activated by environmental haem and quinone and contributes to virulence. Mol Microbiol 56: 525-534.
39. Teng F, Nannini EC, Murray BE, (2005) Importance of gls24 in virulence and stress response of Enterococcus faecalis and use of the Gls24 protein as a possible immunotherapy target. J Infect Dis 191: 472-480.
40. Stroeher UH, Kidd SP, Stafford SL, Jennings MP, Paton JC, et al. (2007) A pneumococcal MerR-like regulator and S-nitrosoglutathione reductase are required for systemic virulence. J Infect Dis 196: 1820-1826.
41. Brown NL, Stoyanov JV, Kidd SP, Hobman JL, (2003) The MerR family of transcriptional regulators. FEMS Microbiol Rev 27: 145-163.
42. Santi I, Scarselli M, Mariani M, Pezzicoli A, Masignani V, et al. (2007) BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood. Mol Microbiol 63: 754-767.
43. Alteri CJ, Mobley HL, (2012) Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Curr Opin Microbiol 15: 3-9.
44. Ueda T, Kaito C, Omae Y, Sekimizu K, (2011) Sugar-responsive gene expression and the agr system are required for colony spreading in Staphylococcus aureus. Microb Pathog 51: 178-185.
45. Iyer R, Camilli A, (2007) Sucrose metabolism contributes to in vivo fitness of Streptococcus pneumoniae. Mol Microbiol 66: 1-13.
46. Jones AL, Knoll KM, Rubens CE, (2000) Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis. Mol Microbiol 37: 1444-1455.
47. Santi I, Maione D, Galeotti CL, Grandi G, Telford JL, et al. (2009) BibA induces opsonizing antibodies conferring in vivo protection against group B Streptococcus. J Infect Dis 200: 564-570.
48. Churchward G, (2007) The two faces of Janus: virulence gene regulation by CovR/S in group A streptococci. Mol Microbiol 64: 34-41.
49. Mascher T, Zahner D, Merai M, Balmelle N, de Saizieu AB, et al. (2003) The Streptococcus pneumoniae cia regulon: CiaR target sites and transcription profile analysis. J Bacteriol 185: 60-70.
50. Trevino J, Perez N, Ramirez-Pena E, Liu Z, Shelburne SA, 3rd,et al CovS simultaneously activates and inhibits the CovR-mediated repression of distinct subsets of group A Streptococcus virulence factor-encoding genes. Infect Immun 77: 3141-3149.
51. Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM, (2006) Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog 2: e5.
52. Lembo A, Gurney MA, Burnside K, Banerjee A, de los Reyes M, et al. (2010) Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration. Mol Microbiol 77: 431-443.